ArticleOncotarget2022

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation.

Raquel Torres-Guzmán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.